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Myeloid Cell-Specific Lipin-1 
Deficiency Stimulates Endocrine 
Adiponectin-FGF15 Axis and 
Ameliorates Ethanol-Induced Liver 
Injury in Mice
Jiayou Wang1, Chunki Kim1, Alvin Jogasuria1, Yoonhee Han1, Xudong Hu1,2, Jiashin Wu1, 
Hong Shen1,3, Roman Chrast4, Brian N. Finck5 & Min You1
Lipin-1 is a phosphatidate phosphohydrolase (PAP) required for the generation of diacylglycerol during 
glycerolipid synthesis, and exhibits dual functions in the regulation of lipid metabolism. Lipin-1 has 
been implicated in the pathogenesis of alcoholic liver disease (ALD). In the present study, we assessed 
lipin-1 function in myeloid cells in ALD using a myeloid cell-specific lipin-1 knockout (mLipin-1KO) 
mouse model. Utilizing the Gao-binge ethanol feeding protocol, matched mLipin-1KO mice and 
littermate loxP control (WT) mice were pair-fed with either an ethanol-containing diet or an ethanol-
free diet (control). Surprisingly, deletion of lipin-1 in myeloid cells dramatically attenuated liver 
inflammatory responses and ameliorated liver injury that would normally occur following the ethanol 
feeding protocol, but slightly exacerbated the ethanol-induced steatosis in mice. Mechanistically, 
myeloid cell-specific lipin-1 deficiency concomitantly increased the fat-derived adiponectin and ileum-
derived fibroblast growth factor (FGF) 15. In concordance with concerted elevation of circulating 
adiponectin and FGF15, myeloid cell-specific lipin-1 deficiency diminished hepatic nuclear factor kappa 
B (NF-κB) activity, limited liver inflammatory responses, normalized serum levels of bile acids, and 
protected mice from liver damage after ethanol challenge. Our novel data demonstrate that myeloid 
cell-specific deletion of lipin-1 ameliorated inflammation and alcoholic hepatitis in mice via activation of 
endocrine adiponectin-FGF15 signaling.
Heavy chronic alcohol consumption, especially when combined with binging, is associated with development of 
alcoholic liver disease (ALD)1. Elevated hepatic inflammation and liver injury are hallmarks of clinical patients 
with ALD1,2. However, pathogenic mechanisms of ethanol-induced inflammation and alcoholic hepatitis are still 
largely unclear. To date, patients with alcoholic hepatitis lack effective treatments.
Lipin-1, a mammalian Mg2+-dependent phosphatidate phosphohydrolase (PAP), is a bi-functional molecule 
that regulates lipid metabolism at multiple levels3. Lipin-1 converts phosphatidate into diacylglycerol through its 
PAP activity and contributes to triglyceride (TG) synthesis. Lipin-1 also translocates into nucleus and interacts 
with DNA-bound transcription factors such as proliferator-activated receptor α , PPARγ coactivator 1α , hepatic 
nuclear receptor 4α , and sterol-response element binding protein 1 to regulate their activities4,5.
While the role of lipin-1 in regulating lipid metabolism is established, accumulating evidences suggest com-
plex and controversial functional roles of lipin-1 in regulating inflammation process6–13. Several studies have 
demonstrated that lipin-1 has potent anti-inflammatory properties6,7,9,10. In adipocytes, lipin-1 inhibited nuclear 
factor activated T cells c4 transcriptional activity in a PAP independent manner, which, in turn, inhibited 
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production of a panel of proinflammatory cytokines6. Inhibition of lipin-1 gene expression also increased mono-
cyte chemoattractant protein-1, a regulator of adipose inflammation7. Furthermore, hepatocyte-specific lipin-1 
ablation significantly increased the mRNA levels of several important pro-inflammatory cytokines, such as tumor 
necrosis factor-alpha (TNF-α ), interleukin-1beta (IL-1β ), lipocalin-2 (Lcn-2) and serum amyloid A-1 (Saa-1), 
in mice9. Conversely, other studies also demonstrated lipin-1 as a major contributor to macrophage proinflam-
matory activation11–13. For instance, upon Toll-Like-Receptor (TLR) stimulation of macrophages from humans 
or lipin-1-deficient mice, the generation of proinflammatory cytokines known to involve in inflammatory pro-
cess was reduced12. This suggests that lipin-1 acts as a proinflammatory mediator downstream of TLR signaling 
and during the development of inflammatory processes in macrophage. Intriguingly, lipin-1 contributed to lipid 
droplet formation in response to fatty acid loading in cultured mouse and human macrophages. The contri-
bution of lipin-1 to glycerophospholipid synthesis was necessary for new membrane generation during B cell 
differentiation, implying that lipin-1 might also link lipid synthesis pathways that contributed to inflammation 
in macrophages7,13.
Emerging evidences suggested that ethanol-mediated alterations in lipin-1 functions contribute to abnor-
malities in the hepatic lipid metabolism and inflammatory processes associated with ALD in rodents and 
human9,10,14–18. We discovered that hepatocyte-specific lipin-1 ablation exacerbated inflammation and aggravated 
the development and progression of experimental steatohepatitis in mice after ethanol challenge, suggesting that 
hepatocyte-specific lipin-1 exerts anti-inflammatory properties in alcoholic steatohepatitis9. However, it remains 
unknown whether and how myeloid cell-specific lipin-1 influences alcoholic steatosis, inflammatory conditions 
and liver injury in vivo.
In the present study, to determine the effects of loss of lipin-1 in myeloid cells on the development and pro-
gression of alcoholic steatohepatitis, we generated a myeloid cell-specific lipin-1 knockout mouse (mLipin-1KO) 
model utilizing a loxP/Cre recombinase system. We demonstrated that ablation of myeloid cell-specific lipin-1 
selectively ameliorated hepatic inflammation but not steatosis in mice after ethanol administration. We also pro-
vided novel evidence demonstrating that the protective effects of myeloid cell-specific lipin-1 deficiency against 
inflammation and liver injury in the ethanol-exposed mice were mediated, at least in part, through coordinated 
elevation and stimulation of two prominent endocrine hormones, adipose-derived adiponectin and gut-derived 
fibroblast growth factor (FGF) 15, and their hepatic signaling.
Results
Myeloid cell-specific lipin-1 deficiency protected mice from ethanol-induced liver injury but 
mildly aggravated steatosis. Our mLipin-1KO mice, generated with the loxP/Cre recombinase system, 
were viable and phenotypically normal under a chow diet9,19. The role of myeloid cell-specific lipin-1 deficiency 
on alcoholic steatohepatitis was investigated by pair-feeding wild-type (WT) and mLipin-1KO mice utilizing a 
Gao-binge ethanol feeding protocol20.
As expected, ethanol feeding to WT mice significantly increased the levels of hepatic TGs and cholesterol 
compared with their pair-fed WT controls (Fig. 1A,B). The increases in hepatic TGs and cholesterol were more 
pronounced in the ethanol-fed mLipin-1LKO mice than their corresponding pair-fed WT mice (Fig. 1A,B). H&E 
staining analysis confirmed that ethanol administration slightly augmented accumulation of lipid droplets in 
livers of mLipin-1LKO mice compared to the other three groups (Fig. 1C).
Serum alanine transaminase (ALT), an indicator of liver damage, was significantly elevated in the ethanol-fed 
WT compared to WT control mice (Fig. 1D). Surprisingly, the ethanol-feeding-associated elevation of serum 
ALT was significantly reduced in the mLipin-1KO mice compared to WT mice (Fig. 1D). Concordantly, the 
serum levels of aspartate aminotransferase (AST) in the mLipin-1KO mice were the lowest among all groups 
(Fig. 1E).
Collectively, the data demonstrated that myeloid cell-specific lipin-1 deficiency ameliorated liver damaged but 
slightly exacerbated steatosis in mice after ethanol administration.
Myeloid cell-specific lipin-1 deficiency ameliorated hepatic inflammation by ethanol in mice. 
Neutrophilic inflammation contributes to the ethanol-induced hepatic dysfunction and injury21. As illustrated in 
Fig. 2A, hepatic myeloperoxidase (MPO) activity was significantly increased in both the ethanol-fed WT mice and 
ethanol-fed mLipin-1KO mice compared to WT controls. However, in comparison to the ethanol-fed WT mice, 
ethanol-fed mLipin-1KO mice displayed significantly lower levels of hepatic MPO activity (Fig. 2A). Examination 
of liver histology with MPO staining revealed that neutrophil infiltration was markedly higher in livers from the 
ethanol-fed WT mice compared to WT controls (Fig. 2B). However, fewer MPO+ neutrophils infiltrated livers 
of the ethanol-fed mLipin-1KO mice compared with ethanol-fed WT mice (Fig. 2B). Accordingly, while ethanol 
feeding to WT mice significantly increased hepatic gene expression of a neutrophil marker, Ly6G, Ly6G mRNA 
levels were substantially reduced in the mLipin-1KO mice fed either with or without ethanol compared to WT 
controls, confirming that myeloid cell-specific lipin-1 deficiency attenuated hepatic neutrophilic inflammation in 
the ethanol-administrated mice (Fig. 2C).
Further analysis of inflammatory markers revealed that hepatic expressions of the macrophage marker, 
F4/80+, and of monocyte/macrophage marker, CD68, were substantially decreased in the ethanol-fed WT mice 
and in the mLipin-1KO mice fed either with or without ethanol in comparison to WT controls, suggesting that 
ethanol feeding might increase apoptosis of F4/80+-positive Kupffer cells (Fig. 2C)20,22. Contrary to our previous 
results obtained with the Gao-binge ethanol feeding protocol14, hepatic gene expressions of the proinflammatory 
factors, tumor necrosis factor alpha (TNF-α ) and Interleukin 6 (IL-6), were suppressed in the ethanol-fed WT 
mice and in the mLipin-1KO mice fed either with or without ethanol (Fig. 3A). These discrepancies could be 
resulted from differences in the genetic backgrounds of the mice (C57BL/6J and SV12914 vs. C57BL/6J9) and 
could be due to differences in their diet compositions (low fat14 vs. high-polyunsaturated fat20).
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Figure 1. Myeloid cell-specific lipin-1 deficiency alleviated experimental alcoholic steatohepatitis in mice. 
Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed either a control diet or an ethanol-containing diet 
for 10 days followed by single gavage of ethanol. (A) Liver triglyceride (TG) levels. (B) Liver cholesterol (CHO) 
levels. (C) Immunohistochemical staining for Hematoxylin and eosin (H&E) (original magnification × 40) of 
liver sections (D) Serum ALT. (E) Serum AST. Results are expressed as means ± SEM (n = 4–6 mice). Means 
without a common letter differ, P < 0.05.
Figure 2. Myeloid cell-specific lipin-1 deficiency alleviated experimental alcoholic steatohepatitis in mice. 
Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed either a control diet or an ethanol-containing diet for 
10 days followed by single gavage of ethanol. (A) Liver MPO activity. (B) Immunohistochemical staining for 
MPO (original magnification × 40) of liver sections. (C) Relative liver mRNA levels of F4/80+, CD68, and Ly6G 
were analyzed by real-time PCR (qRT-PCR). Results are expressed as means ± SEM (n = 4–6 mice). Means 
without a common letter differ, P < 0.05.
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Interestingly, the serum levels of TNF-α and IL-6 were significantly elevated in the ethanol-fed WT mice 
compared to WT controls, suggesting that the ethanol-mediated increases in circulating TNFα and IL-6 might be 
largely derived from other organs (Fig. 3B,C). The serum levels of TNF-α and IL-6 were markedly reduced in the 
ethanol-fed mLipin-1KO mice compared with ethanol-fed WT mice (Fig. 3B,C).
We further examined gene expressions of M1 and M2 macrophage markers to check the status of macrophage 
polarization in livers of the ethanol-fed mLipin-1KO mice. Strikingly, mRNA gene expression of M1 marker 
Cd11c was nearly depleted whereas M2 marker Arg1 gene expression was mildly increased in livers of the 
ethanol-fed mLipin-1KO mice compared with all other groups (Fig. 3D).
As shown in Fig. 3E, the mRNA levels of IL-1β and NOD-like receptor family, pyrin domain containing 3 
(NLRP3), two inflammasome components, were severely inhibited in the ethanol-fed WT and control diet-fed 
mLipin-1KO mice compared to WT controls. However, ethanol administration to the mLipin-1KO mice dras-
tically decreased the expression of IL-1β , in parallel to a robust decrease in the mRNA expression of NLRP3 
(Fig. 3E).
Hepatic gene expression of MIP-1α and MIP-1β , two potent chemoattractants for monocytes and/or neu-
trophils, were down-regulated in the mLipin-1KO mice fed either with or without ethanol compared to WT 
controls (Fig. 3F). Meanwhile, hepatic mRNA expression of chemokine MCP-1 was markedly reduced in the 
ethanol-fed mLipin-1KO compared to all other groups (Fig. 3F). Additionally, hepatic mRNA levels of adhesion 
molecules ICAM-1 and VCAM-1 were the lowest in the ethanol-fed mLipin-1KO mice compared to all other 
three groups (Fig. 3G). Collectively, these results clearly indicated that myeloid cell-specific lipin-1 deficiency 
drastically diminished inflammation in mice after ethanol administration.
Myeloid cell-specific lipin-1 deficiency reduced circulating levels of lipocalin-2 (Lcn2) and serum 
amyloid A1 (Saa1) in the ethanol-fed mice. We profiled expressions of Lcn2 and Saa-1, two major 
acute-phase molecules involved in regulating the ethanol-mediated inflammation process9,14,21. In comparison 
with the WT pair-fed control mice, Lcn2 mRNA and protein expression levels were significantly elevated in 
livers of the ethanol-fed WT mice, and the increases in Lcn2 gene expression were augmented in the control 
diet-fed mLipin-1KO mice (Fig. 4A–C). However, hepatic Lcn2 mRNA and protein levels in the ethanol-fed 
mLipin-1KO were drastically reduced to levels lower that of the WT controls (Fig. 4A–C). Accordingly, the serum 
levels of Lcn2 were significantly elevated in the ethanol-fed WT mice and control diet-fed mLipin-1KO mice to 
∼ 180% and ∼ 167% of the WT controls, respectively (Fig. 4D). Strikingly, serum Lcn2 levels in the ethanol-fed 
mLipin-1KO mice were markedly reduced to ∼ 48% of WT controls (Fig. 4D).
While hepatic Saa1 gene and protein expression levels were similarly increased in the ethanol-fed WT and 
in control diet-fed mLipin-1KO mice compared to WT controls, ethanol feeding to the mLipin-1KO mice 
Figure 3. Myeloid cell-specific lipin-1 deficiency ameliorated ethanol-induced hepatic inflammation in 
mice. Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed either a control diet or an ethanol-containing  
diet for 10 days followed by single gavage of ethanol. (A) Relative liver mRNA levels of TNF-α and IL-6.  
(B) Serum TNF-α levels. (C) Serum IL-6 levels. (D) Relative hepatic mRNA levels of CD11c and Arg1.  
(E) Relative hepatic mRNA levels of IL-1β and NLRP3. (F) Relative hepatic mRNA levels of MCP-1, MIP-1α 
and MIP-1β. (G) Relative hepatic mRNA levels of ICAM-1 and VCAM-1. Results are expressed as means ± SEM 
(n = 4–6 mice). Means without a common letter differ, P < 0.05.
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drastically decreased Saa1 expression (Fig. 4A–C). Consistently, serum Saa1 levels in the ethanol-fed WT mice 
and control diet-fed mLipin-1 mice were significantly elevated to ∼ 146% and ∼ 134% of WT controls, respec-
tively (Fig. 4E). However, ethanol administration to mLipin-1KO mice robustly reduced circulating Saa1 to 
∼ 62% of WT controls (Fig. 4E).
Taken together, these findings demonstrated that myeloid cell-specific lipin-1 deficiency markedly reduced 
expression and circulating levels of both Lcn2 and Saa1 in the ethanol-administrated mice.
Myeloid cell-specific lipin-1 deficiency induced adipose-derived hormone adiponectin in the 
ethanol-fed mice. Altered adipose adiponectin production and its hepatic signaling have been implicated 
in the pathogenesis of ALD17,23. To understand underlying mechanism contributing to an attenuation of hepatic 
inflammation in the ethanol-fed mLipin-1KO mice, we examined adiponectin and its hepatic signaling.
The serum levels of high-molecular weight (HMW) adiponectin and total adiponectin proteins were similar 
between the WT mice fed either with or without ethanol (Fig. 5A). However, ablation of myeloid cell-specific 
lipin-1 caused a mild increase in circulating total adiponectin and HMW concentrations in the control-diet fed 
mLipin-1KO mice (Fig. 5A). Strikingly, administration ethanol to mLipin-1KO mice led to prominent increases 
in circulating levels of HMW and total adiponectin to ∼ 176% and ∼ 173% of WT control, respectively (Fig. 5A).
Surprisingly, adipose adiponectin mRNA expression was significantly increased in the ethanol-fed WT mice 
compared to WT controls (Fig. 5B). We have previously found that ethanol feeding significantly decreased adi-
pose adiponectin gene expression in mice17,23. This discrepancy may be due to the use of a Lieber-DeCarli chronic 
ethanol feeding protocol in those studies17,23. As shown in Fig. 5B, the increases in adipose adiponectin gene 
expression were further augmented in the mLipin-1KO mice fed either with or without ethanol.
CISD1 (also called MitoNEET) is a protein in the outer membrane of mitochondria and involves in regulating 
the expression, release and production of adiponectin in adipose tissues24. In comparison with the WT con-
trol mice, adipose mRNA levels of CISD1 were significantly increased in the ethanol-fed WT and the increases 
were augmented in the control diet-fed mLipin-1KO control mice (Fig. 5C). More importantly, the ethanol-fed 
mLipin-1KO mice exhibited the highest mRNA levels of CISD1, suggesting that increased CISD1 expression in 
the ethanol-fed mLipin-1KO mice might contribute to the upregulation of adipose adiponectin in these mice 
(Fig. 5C).
Adiponectin transduces its signaling via two major adiponectin receptors (AdipoRs), AdipoR1 and AdipoR2. 
In comparisons with the WT controls, ethanol feeding to WT mice significantly reduced mRNA expression 
of hepatic AdipoR1 and AdipoR2 (Fig. 5D). Interestingly, myeloid cell-specific lipin-1 deficiency substantially 
increased mRNAs of hepatic AdipoR1 and AdipoR2 in mice fed either with or without ethanol to levels higher 
than in the WT pair-fed control mice (Fig. 5D).
Figure 4. Myeloid cell-specific lipin-1 deficiency reduced circulating levels of lipocalin-2 (Lcn2) and serum 
amyloid A1 (Saa1) in mice after ethanol feeding. Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed 
either a control diet or an ethanol-containing diet for 10 days followed by single gavage of ethanol. (A) Relative 
liver mRNA levels of Lcn2 and Saa1. (B) Representative Western analysis of liver Lcn2 and Saa1. (C) Relative 
liver protein levels of Lcn2 and Saa1. (D) Relative serum Lcn2 levels. (E) Relative serum Saa1 levels. Results are 
expressed as means ± SEM (n = 4–6 mice). Means without a common letter differ, P < 0.05.
www.nature.com/scientificreports/
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Taken together, our data demonstrated that myeloid cell-specific lipin-1 deficiency elevated circulating levels 
of HMW and total adiponectin and enhanced hepatic AdipoR1 and AdipoR2 gene expression, which in turn, 
would lead to stimulated hepatic adiponectin signaling in mice after ethanol administration.
Myeloid cell-specific lipin-1 deficiency enhanced ileum FGF15 synthesis and elevated serum 
FGF15 levels in the ethanol-fed mice. Fibroblast growth factor 15 (Fgf15, the mouse ortholog of human 
FGF19) is produced in the intestine and regulates postprandial liver metabolism25,26. Emerging evidences suggest 
association and potential dialogues between the adipocyte-derived adiponectin and ileum FGF15/1926. As such, 
we investigated whether myeloid cell-specific lipin-1 deficiency affects ileum FGF15 and its hepatic receptors and 
their modifications by ethanol administration in mice.
The mRNA levels of ileum FGF15 were mildly but significantly reduced in the ethanol-fed WT mice compared 
to WT controls (Fig. 6A). However, in comparison with the WT controls, ablation of myeloid cell-specific lipin-1 
significantly increased ileum FGF15 mRNAs (Fig. 6A). More strikingly, compared to the WT controls, ethanol 
administration to the mLipin-1KO mice robustly increased, up to ∼ 10-fold, the mRNA expression levels of ileum 
FGF15 (Fig. 6A).
Accordingly, the levels of serum FGF15 were significantly reduced to ∼ 86% in the ethanol-fed WT mice, but 
were enhanced to ∼ 122% in the control diet-fed mLipin-1KO mice, compared to WT control mice (Fig. 6B). 
More importantly, the robust increase of ileum FGF15 gene expression in the ethanol-fed mLipin-1KO mice 
coincided with a substantial increase in serum FGF15 levels to ∼ 152% of the WT controls (Fig. 6B).
As shown in Fig. 6A, although gene expression of intestine farnesoid X receptor (FXR) and Diet 1, two 
known molecules involved in regulating ileum FGF15/19 expression and production, were not affected by 
Figure 5. Myeloid cell-specific lipin-1 led to induction of adipose-derived hormone adiponectin in 
ethanol-administrated mice. Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed either a control diet 
or an ethanol-containing diet for 10 days followed by single gavage of ethanol. (A) Serum protein levels of 
HMW and total adiponectin levels. (B) Relative adipose mRNA levels of adiponectin. (C) Relative adipose 
mRNA levels of CISD1. (D) Relative liver mRNA levels of AdipoR1 and AdipoR2. Results are expressed as 
means ± SEM (n = 4–6 mice). Means without a common letter differ, P < 0.05.
www.nature.com/scientificreports/
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ethanol feeding to WT mice27. The mRNA expression of ileum FXR and Diet1 were mildly increased in the con-
trol diet-fed mLipin-1KO mice compared to WT controls. However, ethanol feeding to the mLipin-1KO mice 
robustly increased gene expressions of ileum FXR and Diet 1 compared to all other groups (Fig. 6A).
In hepatocytes, signaling of FGF15/19 requires the tyrosine kinase membrane receptor fibroblast growth fac-
tor receptor4 (FGFR4) and co-receptor β -Klotho (β KL)25,26. Protein levels of FGFR4 were reduced, as evidenced 
by Western Blot, in livers of the ethanol-fed WT compared to WT controls (Fig. 6C). Hepatic FGFR4 protein 
levels were markedly inhibited in the ethanol-fed mLipin-1 mice compared to all other three groups, consistent 
with the findings that induction of FGF15/19 from ileum was associated with liver FGFR4 deficiency (Fig. 6C).
Taken together, the data demonstrated that myeloid cell-specific lipin-1 deficiency increased ileum FGF15 
synthesis and elevated circulating FGF15 levels in the ethanol-administrated mice.
Myeloid cell-specific lipin-1 deficiency ameliorated the perturbation of bile acid homeostasis 
by ethanol administration in mice. Both adiponectin and FGF15/19 are capable of regulating bile acid 
hemostasis25,26,28,29. Hence, we examined whether hepatic myeloid cell-specific lipin-1 deficiency affects bile acid 
homeostasis.
Liver cholesterol 7α -hydroxylase (Cyp7a1), the rate-limiting enzyme for the “neutral” pathway of bile acid 
synthesis in liver, is partially suppressed by the gut-derived FGF15/1925. As shown in Fig. 6D, in comparison 
with the WT controls, mRNA expression of Cyp7a1 was significantly increased in livers of the ethanol-fed WT 
mice, confirming that the lower circulating levels of FGF15 promoted upregulation of hepatic Cyp7a1 expression. 
Furthermore, hepatic Cyp7a1 mRNAs were significantly repressed in the mLipin-1 mice fed with either a con-
trol diet or an ethanol-containing diet compared with WT controls, indicating that myeloid cell-specific lipin-1 
deficiency-mediated elevation of ileum FGF15 transduced signals to livers of these mice (Fig. 6D).
Hepatic mRNA expression of Cyp27a1, which catalyzes the initial step of the alternative bile acid biosynthetic 
pathway, was significantly suppressed in the ethanol-fed WT mice and the suppression was slightly exacerbated 
in the ethanol-fed mLipin-1KO mice (Fig. 6D). Interestingly, mRNA level of Cyp8b1, a key enzyme controlling 
synthesis of cholic acid, was significantly elevated in the ethanol-fed WT mice, and in the mLipin-1KO mice fed 
either with or without ethanol compared to WT control mice (Fig. 6D).
Ethanol feeding to WT mice significantly increased serum bile acid to ∼ 130% of the WT controls, indicating 
dysregulated bile acid homeostasis in the ethanol-fed WT mice (Fig. 6E). Remarkably, serum levels of total bile 
acid in the ethanol-fed mLipin-1KO mice were reduced to ∼ 90% of WT controls (Fig. 6E).
Myeloid cell-specific lipin-1 deficiency attenuated the NF-κB signaling activation by ethanol 
administration in mice. We investigated nuclear Factor Kappa B (NF-kB) signaling in the mechanism of 
Figure 6. Myeloid cell-specific lipin-1 deficiency increased ileum FGF15 synthesis and normalized serum 
levels of bile acids in ethanol-fed mice. Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed either a 
control diet or an ethanol-containing diet for 10 days followed by single gavage of ethanol. (A) Relative ileum 
mRNA levels of FGF15, FXR and Diet 1. (B) Serum levels of FGF15. (C) Protein levels of hepatic FGFR4.  
(D) Relative liver mRNA levels of Cyp7a1, Cyp27a1 and Cyp8b1. (E) Serum bile acid levels. Results are 
expressed as means ± SEM (n = 4–6 mice). Means without a common letter differ, P < 0.05.
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attenuating hepatic inflammatory process by myeloid cell-specific lipin-1 deficiency. Ethanol feeding to WT mice 
stimulated NFκ B activity, as revealed by increased levels of acetylated NF-κ B and of phosphorylated Iκ Bα and 
a lower level of Iκ Bα level compared to the WT control mice (Fig. 7A,B). Activation of NF-κ B, particularly the 
levels of p-Iκ Bα , was markedly reduced in livers of the ethanol-fed mLipin-1KO mice compared to all other 
groups (Fig. 7A,B).
Collectively, these results demonstrated that myeloid cell-specific lipin-1 deficiency attenuated hepatic NF-κ B 
activity and subsequently reduced inflammation and liver injury by ethanol in mice.
Recombinant FGF19 inhibited Lcn2 and Saa1 gene expressions in cultured mouse AML-12 
hepatocytes. We examined whether FGF15/FGF19 regulates Lcn2 and Saa1 gene expressions in cultured 
mouse AML-12 hepatocytes. Treatment with recombinant FGF19 for 24 hours significantly inhibited mRNA 
expressions of Lcn2 and Saa1 in a dose-dependent manner with a maximal effect at 50 ng/ml in AML-12 cells 
(Supplementary Fig. S1).
Furthermore, although Lcn2 mRNA levels were significantly increased by treatment with lipopolysaccha-
ride (LPS) (100 ng/ml) or ethanol (50 mM), co-incubation with FGF19 (50 ng/ml) completely abolished the 
ability of LPS or ethanol to induce Lcn2 gene expression in AML-12 cells (Supplementary Fig. S1). The ability 
of LPS to induce Saa1 gene expression was also largely blunted by FGF19 treatment (Supplementary Fig. S1). 
Interestingly, co-incubation of FGF19 did not affect the ethanol-mediated induction of Saa1 mRNA abundance 
(Supplementary Fig. S1).
Collectively, these data demonstrated that recombinant FGF19 attenuated Lcn2 gene expression in AML-12 
hepatocytes exposed to LPS or ethanol. Furthermore, FGF19 diminished the Saa1 gene expression stimulated by 
LPS but not by ethanol in AML-12 cells.
Adiponectin and FGF19 regulated each other’s gene expression in mice. We evaluated whether 
FGF15/19 regulates adipose adiponectin expression by treating mice with recombinant FGF19. Adipose adi-
ponectin mRNA expression levels were significantly increased and hepatic Cyp7a1 mRNA levels were suppressed 
(Fig. 7C) in the FGF19-treated mice compared to vehicle-injected control mice. More strikingly, in comparison 
to the WT control mice, FGF15 knockout (FGF15KO) mice displayed significantly lower adipose adiponectin 
mRNA abundance and higher hepatic Cyp7a1 mRNA expression (Fig. 7D).
Figure 7. Myeloid cell-specific lipin-1 deficiency attenuated hepatic NF-kB activity in the ethanol 
administrated mice. Wild-type (WT) or mLipin-1KO (KO) mice were pair-fed either a control diet or an 
ethanol-containing diet for 10 days followed by single gavage of ethanol. (A) Representative Western analysis 
of liver Ac-NF-κ B, NF-κ B, p-Iκ Bα and Iκ Bα . (B) Relative liver protein levels of liver Ac-NF-κ B, NF-κ B, p-Iκ 
Bα and Iκ Bα . (C) Male C57/6J mice were treated by intraperitoneal injection 1 mg/kg mouse body weight 
of recombinant FGF19 for six hours. Relative adipose mRNA levels of adiponectin. Relative liver mRNA of 
Cyp7a1. (D) Male intestinal FGF15 knock out (FGF15KO) mice and LOX littermates (WT) mice were fed 
chow diets. Relative adipose mRNA levels of adiponectin. Relative liver mRNA levels of Cyp7a1. (E) Male 
C57/6J mice were treated by intraperitoneal injection with 0.5 μ g/g mouse body weight of recombinant human 
globular adiponectin (gAcrp) for three days. Relative ileum FGF15. Relative liver mRNA of Cyp7a1. Results are 
expressed as means ± SEM (n = 4–6 mice). Means without a common letter differ, P < 0.05.
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To investigate the effect of adiponectin on ileum FGF15 synthesis, we treated mice with recombinant globu-
lar adiponectin (gAcrp), and observed significantly higher expression levels of ileum FGF15 mRNA compared 
to the controls (Fig. 7E). Paradoxically, hepatic Cyp7a1 mRNA levels were slightly increased in gAcrp-treated 
mice compared to controls, implying that gAcrp may also directly regulate hepatic Cyp7A1 gene expression 
(Fig. 7E)28,29.
Taken together, these observations suggest a reciprocal regulation of adiponectin and FGF15/19 gene expres-
sion in mice.
Discussion
In the present study, utilizing a mLipin-1KO mouse model, we unveiled an important role of myeloid cell-specific 
lipin-1 in experimental alcoholic steatohepatitis in mice. Myeloid cell-specific lipin-1 deficiency diminished 
hepatic inflammation, dramatically attenuated hepatic expression of a panel of inflammatory mediators, and 
alleviated the ethanol-induced liver injury in mice. Mechanistically, ethanol administration to mLipin-1KO mice 
increased gene expression and serum levels of the adipose-derived adiponectin and of ileum-derived FGF15. 
Through activating endocrine adiponectin-FGF15 axis, mLipin-1 deficiency normalized serum bile acid lev-
els, inhibited hepatic NF-κ B signaling, limited inflammation, and thus, protected liver from ethanol-induced 
damage. Altogether, our findings demonstrated that myeloid cell-specific deletion of lipin-1 ameliorated hepatic 
inflammation but not steatosis and alleviated liver injury in the ethanol-fed mice largely via induction of endo-
crine adiponectin-FGF15 axis and stimulation of adiponectin-FGF15 mediated hepatic signaling (Fig. 8).
In contrast to lipin-1 in the hepatocyte, which plays an anti-inflammatory role in the development and pro-
gression of alcoholic steatohepatitis in mice9, mLipin-1KO mice exhibited less hepatic inflammation and less 
liver injury but slightly worse steatosis following the ethanol administration. It is likely that lipin-1 regulates 
the inflammation process, and contributes to the development of alcoholic liver injury by cell-specific mech-
anisms. Two lipin-1 protein isoforms, lipin-1α (891 amino acids) and lipin-1β (924 amino acids), are derived 
from Lpin 1 alternative mRNA splicing in liver3. Previously, we observed that lipin-1α but not lipin-1β exerted 
anti-inflammatory actions in macrophages exposed to ethanol or LPS10. Therefore, we speculate that genetic abla-
tion of myeloid cell-specific lipin-1 may affect mainly lipin-1β but not lipin-1α . In this scenario, the diminished 
inflammatory responsiveness to ethanol in the mLipin-1KO mice could be due to a loss of lipin-1β function in 
myeloid cells.
The precise mechanisms underlying the interplay between adiponectin and FGF15 and how hepatic 
adiponectin-FGF15 signaling is affected by ethanol and myeloid cell-specific lipin-1 remain to be determined. 
Figure 8. Proposed mechanisms of the protective action of myeloid cell-specific deficiency against 
experimental alcoholic hepatitis in mice. Following chronic-binge ethanol feeding, myeloid cell-specific 
lipin-1 deficiency induces the adipose-derived adiponectin and gut-derived FGF15 in mice. Elevated levels 
of adiponectin and FGF15 subsequently attenuate hepatic inflammation, and thus, alleviates experimental 
alcoholic hepatitis in mice.
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Because both hormones are anti-inflammatory, they could exert their beneficial effects independently in the livers 
of ethanol-fed mLipin-1 mice30,31. On the other hand, adiponectin could be a critical driver of the liver improve-
ments elicited by FGF15. Elevated FGF15 in the ethanol-fed mLipin-1 mice might also facilitate liver responses 
to adiponectin. Given that adiponectin and FGF15/19 share many signaling pathways and modulate common 
targets, adiponectin and FGF15 may also synergistically or additively exert anti-inflammatory effects and alleviate 
liver injury in the mLipin-1KO mice after ethanol administration. Additional ethanol feeding experiments using 
intestine-specific FGF15 knockout mice administrated with recombinant adiponectin or using adiponectin null 
mice treated with recombinant FGF15/19 should clarify the relative contributions of these endocrine hormones 
to the ethanol-mediated hepatic inflammatory process and alcoholic liver injury. The precise role of endocrine 
adiponectin-FGF15/19 axis in the context of experimental ALD in mice is currently under investigation in our 
laboratory.
Another important finding of the present study is that adiponectin and FGF15/19 regulate each other’s gene 
expression in mice, confirming an association and cross-talk between adipose adiponectin and ileum FGF15/1926. 
However, the precise mechanisms by which adiponectin and FGF15/19 affect each other’s gene expression and 
their secretion remain to be elucidated. In adipocytes, mitoNEET (CISD1) can regulate adiponectin both tran-
scriptionally and post-transcriptionally24. Interestingly, we found that induction of mitoNEET and adiponec-
tin gene expression in adipose tissues of the ethanol-fed mLipin-1KO mice shared a similar pattern. Thus, it is 
tempting to speculate that ileum FGF15 may upregulate adipose adiponectin via modulation of mitoNEET. The 
events and signaling pathways triggered by adiponectin or FGF15/19 to regulate each other’s gene expression 
and secretion warrants investigation. The precise cellular events by which myeloid cell-specific lipin-1 deficiency 
up-regulates hepatic AdipoR1/AdipoR2 levels remain to be investigated. AdipoR1/R2 expression are known to 
be inhibited by inflammatory signals, such as LPS and reactive oxygen species32,33. We have demonstrated that 
myeloid cell-specific lipin-1 deficiency elicits anti-inflammatory effects in mice. Therefore, it is logical to specu-
late that myeloid cell-specific lipin-1 deficiency may up-regulate hepatic AdipoR1/R2 via it’s anti-inflammatory 
properties in mice.
It is intriguing that deletion of lipin-1 in myeloid cells resulted in ileum FGF15 induction in the ethanol-fed 
mice. In intestine, both FXR and Diet 1 are major regulators of FGF15 synthesis and production25,27. Given that 
ethanol feeding to mLipin-1KO mice robustly increased gene expressions of FXR and Diet 1 in intestine, FXR and 
Diet 1 might directly involve in upregulating FGF15 in the mLipin-1KO mice in response to ethanol challenge. 
Furthermore, ileum FGF15/19 is known to be produced in response to bile acid absorption acting on the FXR25,27. 
Therefore, we speculate that myeloid cell-specific lipin-1 deficiency might induce bile acid absorption in ileum 
or modulate the intestinal synthesis of a specific bile acid which, in turn, lead to FGF15 induction in mice after 
ethanol administration. On the other hand, myeloid cell-specific lipin-1 deficiency might indirectly upregulate 
ileum FGF15 through enhanced adiponectin signaling in ethanol-fed mice.
Both Lcn2 and Saa-1 have recently been identified as major players in driving inflammation and causing 
development and progression of alcoholic steatohepatitis in rodents and human9,14,21,34. It is intriguing that the 
myeloid cell-specific lipin-1 deficiency drastically reduced the expressions and levels of Lcn2 and Saa1 in the eth-
anol administrated mice. Lcn2 plays an important role in promoting neutrophil infiltration in the pathogenesis of 
ALD21. The lower level of Lcn2 might be response for the attenuated neutrophil infiltration observed in the livers 
of ethanol-fed mLipin-1KO mice.
We provided evidences for the first time that the ileum-derived FGF19 repressed gene expressions of Lcn2 
and Saa1 in cultured AML-12 hepatocytes. We have also observed that co-administration of recombinant adi-
ponectin to the ethanol-fed mice abolished the ability of ethanol to up-regulate hepatic Lcn2 and Saa1 and alle-
viated alcoholic fatty liver injury in mice (M.Y., unpublished data). Therefore, we speculate an interplay between 
the adiponectin-FGF15/19 axis and Lcn2-Saa1 axis being coordinately regulated by ethanol and the myeloid 
cell-specific lipin-1. Giving that alcoholic liver injury is driven by organ cross-talks, it is also likely that adiponec-
tin, FGF15/19, Lcn2 and Saa1 serve as crucial endocrine mediators in the cross-talks among adipose, intestine, 
and liver in the pathogenesis of ALD1–3.
In summary, our current findings suggest that reducing the myeloid cell-specific lipin-1 selectively attenuates 
the inflammatory responses and ameliorate liver damage by ethanol consumption in mice. More importantly, we 
provide novel mechanistic insights in the cooperative actions of adiponectin and FGF15 and their hepatic sign-
aling in protecting liver from ethanol-induced injury in the mLipin-1KO mice. Further investigations are nec-
essary before our current findings in mice can be translated to human. Several lines of evidence have suggested 
that ethanol-mediated dysregulation of lipin-1 function may contribute to the development and progression of 
human ALD14,35. Whether targeted modulation of myeloid cell-specific lipin-1 can provide therapeutic benefits 
in controlling the ethanol-induced inflammatory conditions in human should be the focus of future research. 
Our current findings also raise exciting possibilities of novel treatment strategies for human alcoholic hepatitis 
utilizing pharmacological modulation of the endocrine adiponectin-FGF15/19 axis.
Methods
Generation of myeloid cell-specific lipin-1 knockout (mLipin-1KO) mice. Lipin-1loxP/loxP mice 
were generated as described previously9,19. Mice expressing Cre recombinase driven by the lysozyme promoter 
[Lysozyme-Cre mice, (B6.129P2-lyz2tm1(cre)Ifo/J)] were purchased from Jackson Laboratory (Bar Harbor, ME, 
USA). Lipin-1flox/flox and LysM-Cre mice were crossed to generate myeloid cell-specific lipin-1 knockout mice 
(mLipin-1KO) mice (genetic background: C57BL/6 and SV129 background). Lipin-1flox/flox Lysozyme-Cre+ 
(mLipin-1KO) and their age-matched Lox controls (WT) were used for the studies. All the animal experiments 
were approved by the Institutional Animal Care and Use Committee of Northeast Ohio Medical University 
(NEOMED). All the experiments were performed in accordance with the relevant guidelines and regulations.
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Ethanol feeding experiments. Liquid diets were based on the Lieber-DeCarli formulation and provided 
1 kcal/ml (prepared by Frenchtown, New Jersey, USA). A mouse model of chronic plus single binge ethanol con-
sumption (referred as Gao-binge model) was used as described20. Male mLipin-1KO mice and their age-matched 
littermate Lox controls (WT) older than ten to twelve weeks of age were divided into four dietary groups: (1) WT 
control; (2) WT plus ethanol (E; identical to the control diet but with 5% w/v ethanol added); (3) mLipin-1KO 
control; (4) mLipin-1KO plus ethanol. All mice were first fed a liquid control diet for 5 days. Ethanol groups were 
then fed a liquid diet containing 5% w/v ethanol for 10 days while control mice were pair-fed to their ethanol fed 
counterparts for 10 days. At day 11, mice in ethanol groups were given a single dose of ethanol gavage (5 g/kg 
body weight, 20% ethanol), while mice in WT or mLipin-1KO control groups were given an isocaloric dose of 
dextrin maltose gavage. The gavage was performed in the early morning, and mice had access to the diets after 
alcohol gavage. The mice were euthanized and blood and tissue samples were collected 9 h post-gavage. Liquid 
diets were freshly prepared from powder daily. For mice on an ethanol-containing diet, animal cages were placed 
on heating pads to maintain body temperature to compensate for potential alcohol-induced hypothermia. Food 
intake was recorded daily. During the entire feeding period, mLipin-1KO mice and their WT counterparts were 
observed to consume similar volumes of ethanol containing-diets.
Recombinant adiponectin or recombinant FGF19 treatment in mice. 10–13 week old male 
C57BL/6J mice were treated by intraperitoneal injection with 0.5 μ g/g mouse body weight of recombinant human 
globular adiponectin (gAcrp) (Shenandoah Biotech, Warwick, PA) for three days in PBS or vehicle (PBS). 12 week 
old male C57BL/6J mice were treated by intraperitoneal injection with 1 mg/kg mouse body weight of recombi-
nant FGF19 (Gold Biotech, St. Louis, MO) in PBS or vehicle (PBS) and then sacrificed six hours later. Then all the 
mice were euthanized, blood, liver, adipose tissue and terminal small intestine (ileum) samples were collected.
FGF15 knockout mice (FGF15KO). FGF15KO (FGF15KO) mice were kindly provided by Dr. Rohit Kohli 
(Cincinnati Children’s Hospital Medical Center). Those mice are on the C57BL/6J genetic background.
Liver Histology. Liver tissues were fixed in 10% formalin and embedded in paraffin. Embedded liver tis-
sues were sectioned and then stained with hematoxylin and eosin (H&E)9. Embedded liver tissues were also 
subjected to immunohistochemical staining for MPO by using rabbit anti-MPO polyclonal antibody (Abcam 
Inc, Cambridge, MA). Sections were incubated with Alexa Fluor 488 conjugated-goat anti-rabbit IgG secondary 
antibody (Thermo Fisher Scientific, Rockford, IL) for a MPO antibody. Positive cells for MPO were randomly 
photographed using a fluorescence microscope, and positive density was quantified using the software Image-Pro 
Plus (Media Cybernetics, Bethesda, MD).
Biochemical analysis. Liver triglyceride cholesterol was measured as described previously9,14.
ELISA Assays of animal Serum. Serum levels of ALT and AST were determined using the MaxDiscovery 
ALT (3460-08) and AST (5605-01) Assay Kits (Bioo-Scientific, Austin, TX). Plasma or tissue fatty acids, triglyc-
eride and cholesterol were determined using the Infinity Cholesterol (TR13421) and Triglyceride (TR22421) 
Reagents (Thermo Scientific, Waltham, MA). Serum level of Lcn2 was measured by Lipocalin-2/ab199083 Mouse 
ELISA Kit (Abcam, Cambridge, MA). Serum level of Saa1 was measured by Saa1/ab157723 Mouse Elisa Kit 
(Abcam, Cambridge, MA). Serum level of FGF15 was measured by FGF15/LS-F11446 Mouse Elisa Kit (LifeSpan 
BioSciences, Inc, Seattle, WA). Serum levels of total adiponectin were determined using a commercial ELISA 
kit from BioVendor (Candler, NC). Serum levels of HMW forms of adiponectin were determined with Mouse 
Adiponectin Assay Kit from ALPCO # 47-ADPMS-E01 (Salem, NH). Concentrations of total bile acids in serum 
were determined using a 3α -hydroxysteroid dehydrogenase method (Diazyme). Analyses were performed with a 
SpectraMax i3x microplate reader (Molecular Devices, Sunnyvale, CA).
Expression analyses. Liver, adipose tissues, and ileal samples were collected for mRNA analysis. The ileal 
samples were taken approximately 2 cm away from the ileo-cecal junction. Total RNA was extracted using the 
RNeasy kit (Qiagen) and cDNA was prepared using the Quantitech Reverse Transcription kit (Qiagen). Real-time 
quantitative PCR (qPCR) amplification was performed using the CFX96 Touch Real-Time PCR Detection System 
(Bio-Rad Laboratories) with FastStart Universal SYBR Green Master Mix with ROX (Roche Diagnostics)9,14. 
Relative mRNA levels were calculated using the comparative cycle threshold (Ct) method and were normalized 
to the values of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels. The qPCR primers used in 
this study are listed in Table S1 (Supplementary Table S1).
Western blot analyses were performed by separating liver extracts by electrophoresis in 10% and/or AnyKd 
Mini-Protean TGX gels using Bio-Rad Mini-PROTEAN Tetra Cell System and transferred to PVDF mem-
branes via Bio-Rad Blotting Module9,14. Multiple protein band quantification and analysis were performed using 
AlphaView software version 3.4 (ProteinSimple). SIRT1, NF-κ B, acetylated NF-κ B and GAPDH antibodies were 
purchased from Cell Signaling Technology (Danvers, MA). Lcn2, Saa1, and FGFR4 antibodies were purchased 
from Abcam (Cambridge, MA).
Studies with Mouse AML-12 cells Hepatocytes. Mouse AML-12 hepatocytes (American Type Culture 
Collection, Manassas, VA) were cultured in DMEM/F12 medium supplemented with 10% fetal bovine serum 
(FBS), 100 μ g/ml streptomycin, 63 μ g/ml penicillin G, 0.1 μ M dexamethasone, and insulin-transferrin-selenium 
(ITS; Gibco-BRL). For the treatment, hepatocytes were grown at 37 °C in an atmosphere of 5% CO2. At ∼ 80% 
confluence, the cells were then incubated overnight in a serum-free medium.
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Statistical analysis. All results are provided as means ± standard errors (SEM). Statistical analysis was per-
formed using GraphPad Prism (San Diego, CA). The significance of differences between two groups was deter-
mined by unpaired two-tailed Student’s t-test. For comparison of multiple groups, one-way analysis of variance 
(ANOVA) test followed by the post-hoc Bonferroni test was applied. Significance was accepted at a p value of 
< 0.05.
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